VentriPoint Diagnostics (FRA:5V7) FFO


FRA:5V7 VentriPoint Diagnostics Ltd FRA:5V7
9 GF Score
Price €0.06
! 4 Warning Signs
View Full Analysis

What is VentriPoint Diagnostics FFO?

FFO (Funds from operations) only applies to REITs.

FRA:5V7
9GF Score
VentriPoint Diagnostics Ltd FRA:5V7
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

VentriPoint Diagnostics Business Description

Other Exchanges VPTDF:USAVPT:Canada
Address 18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. Its flagship product, the Ventripoint Medical System (VMS+), transforms standard 2D and 3D echocardiography and MRI images into accurate three-dimensional heart models and volumetric measurements, enabling clinicians to assess disease severity, track progression, evaluate treatment response, and guide surgical and pharmacological decisions. Additionally, the company has developed VMS+ 3D Echo and MRI software that can be installed on any personal workstation to create a 3D model of the heart's chamber. Geographically, its products are sold in Canada and internationally.
9GF Score

Get the complete analysis for FRA:5V7

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.06
Price